These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18057435)

  • 1. An update of treatment options for neovascular age-related macular degeneration.
    Iu LP; Kwok AK
    Hong Kong Med J; 2007 Dec; 13(6):460-70. PubMed ID: 18057435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of antiangiogenic agents in age related macular degeneration].
    Tomi A
    Oftalmologia; 2010; 54(4):63-72. PubMed ID: 21516865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comments on current therapeutic possibilities for neovascular age-related macula degeneration].
    Klin Monbl Augenheilkd; 2006 Apr; 223(4):271-8. PubMed ID: 16639662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab for the treatment of neovascular age-related macular degeneration.
    Pitlick JM; Vecera KF; Barnes KN; Reski JW; Forinash AB
    Ann Pharmacother; 2012 Feb; 46(2):290-6. PubMed ID: 22274144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
    Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ;
    Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.
    Bottoni F; Massacesi A; Cigada M; Viola F; Musicco I; Staurenghi G
    Arch Ophthalmol; 2005 Dec; 123(12):1644-50. PubMed ID: 16344434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of treatments for macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials.
    Liu M; Regillo CD
    Curr Opin Ophthalmol; 2004 Jun; 15(3):221-6. PubMed ID: 15118509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA; Rosenfeld PJ
    Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of age-related macular degeneration.
    Bylsma GW; Guymer RH
    Clin Exp Optom; 2005 Sep; 88(5):322-34. PubMed ID: 16255691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the pharmacotherapy of neovascular age-related macular degeneration.
    Freund KB; Mrejen S; Gallego-Pinazo R
    Expert Opin Pharmacother; 2013 Jun; 14(8):1017-28. PubMed ID: 23560774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidance for the treatment of neovascular age-related macular degeneration (AMD)].
    Karska-Basta I; Kubicka-Trzaska A; Oleksy P; Romanowska-Dixon B
    Przegl Lek; 2009; 66(11):972-5. PubMed ID: 20297641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy in exudative age-related macular degeneration.
    Figurska M; Wierzbowska J; Robaszkiewicz J
    Klin Oczna; 2010; 112(7-9):223-9. PubMed ID: 21117365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab: new drug. Macular degeneration: second-line use due to risks.
    Prescrire Int; 2008 Feb; 17(93):3-6. PubMed ID: 18354841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.
    Tufail A; Patel PJ; Egan C; Hykin P; da Cruz L; Gregor Z; Dowler J; Majid MA; Bailey C; Mohamed Q; Johnston R; Bunce C; Xing W;
    BMJ; 2010 Jun; 340():c2459. PubMed ID: 20538634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM
    Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-related macular degeneration; therapeutic options].
    La Heij EC; Liem AT; Hendrikse F
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapeutic approaches in neovascular age-related macular degeneration.
    Nguyen DH; Luo J; Zhang K; Zhang M
    Discov Med; 2013 Jun; 15(85):343-8. PubMed ID: 23819948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of drug options in age-related macular degeneration therapy and potential new agents.
    Yeoh J; Sims J; Guymer RH
    Expert Opin Pharmacother; 2006 Dec; 7(17):2355-68. PubMed ID: 17109611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.